Results 131 to 140 of about 16,882 (251)

[Change from Sjögren syndrome to Sjögren disease]. [PDF]

Beijing Da Xue Xue Bao Yi Xue Ban
Liu Y, Shi G.
europepmc   +1 more source

Limited Efficacy of Autologous Mesenchymal Stromal Cell Injections in Immunomodulatory‐Dependent Dogs With Aqueous Deficient Dry Eye Disease

Veterinary Ophthalmology, Volume 29, Issue 5, September 2026.
ABSTRACT Objective Aqueous deficient dry eye disease (ADDE) results from a quantitative reduction in aqueous tears. We sought to determine the clinical effect of autologous mesenchymal stromal cell (MSC) injections into the region of the lacrimal gland and the gland of the third eyelid in immunomodulatory‐dependent ADDE‐affected dogs. Methods Dogs (n = 
Brian C. Leonard, Shin Ae Park, Sun Young Kim, Kei Hayashi, Sara M. Thomasy, Vanessa Rozo, Monica J. Motta, Dori L. Borjesson, Christopher J. Murphy, Kathryn L. Good   +9 more
wiley   +1 more source

Pregnancy and Assisted Reproductive Outcomes in Women with Systemic Lupus Erythematosus, Sjögren Syndrome and Antiphospholipid Syndrome: An Umbrella Review. [PDF]

J Clin Med
Yue C, Huang W, Han J, Zhang Y, Zeng X, Gao R, Qin L.   +6 more
europepmc   +1 more source

Breast Cancer Incidence in Sjögren Syndrome Patients. [PDF]

J Clin Med
Tsai JJ, Liu LT, Wang SI, Wei JC.
europepmc   +1 more source

Renal tubular acidosis as the initial presentation of Sjögren syndrome complicated by iatrogenic central pontine myelinolysis: a case report. [PDF]

Encephalitis
Algahtani H, Shirah B, Alameen MNA, Almajadiah S, Saeed AB.   +4 more
europepmc   +1 more source

Beyond Glucocorticoids: The Current Landscape and Prospects for Treating Immune Checkpoint Inhibitor‐Induced Autoimmunity

ACR Open Rheumatology, Volume 8, Issue 8, August 2026.
The rapid integration of immune checkpoint inhibitors (ICIs) into standard oncology protocols has birthed a new frontier in clinical rheumatology: immune‐related adverse events (irAEs). By disrupting the programmed cell death‐1 (PD‐1)/PD‐L1 and cytotoxic T‐lymphocyte‐associated protein 4 (CTLA‐4) axes to restore antitumor T cell activity, these ...
Xizi Hu, Ji Eun Ryoo, Brian S. Henick, Adam Mor   +3 more
wiley   +1 more source

B‐Cell Depletion Relative to Tumor Necrosis Factor Inhibition Extends the Duration of Viral Shedding in COVID‐19 Among Autoimmune Disease Patients: A Matched Prospective Cohort Study

ACR Open Rheumatology, Volume 8, Issue 8, August 2026.
Objective To investigate SARS‐CoV‐2 viral shedding duration in autoimmune patients using B cell depleting (BCD) therapy or tumor necrosis factor inhibitors (TNFi) and immunocompetent comparators. Methods We conducted a matched cohort analysis among participants in POSITIVES, a prospective study enrolling outpatients with acute COVID‐19 within five days
Liya Sisay Getachew, Xiaosong Wang, Naomi J. Patel, Zachary S. Wallace, Lauren A. O'Keeffe, Madison Negron, Jiaqi Wang, Grace Qian, Alene A. Saavedra, Kevin T. Mueller, Natalie Davis, Yijia Li, Brooke M. Leeman, Manish C. Choudhary, Sebastien Haneuse, Luke Benz, Julie Boucau, Gregory E. Edelstein, Owen T. Glover, Yumeko Kawano, Rinki Deo, Zahra Reynolds, Karry Su, Chase B. Mandell, Zoie Smith‐Sparks, Eliza Passell, Mamadou Oury Barry, Dessie Tien, Sarah P. Hammond, Gaurav D. Gaiha, Jacob E. Lemieux, Amy K. Barczak, Jonathan Z. Li, Mark J. Siedner, Jeffrey A. Sparks   +34 more
wiley   +1 more source

The Impact of Perfluoroalkyl Substances on the Clinical Manifestations of Primary Sjögren Syndrome. [PDF]

Toxics
Zhao Y, Jin H, Hu S, Zhang S, Zhao M, Xue J.   +5 more
europepmc   +1 more source

Passive Transfer of Hepatitis B Core Antibody Following Intravenous Ig Administration: Clinical Implications and Considerations

ACR Open Rheumatology, Volume 8, Issue 8, August 2026.
Background Intravenous Ig (IVIG) is used in the management of a wide array of medical conditions. Passive transfer of hepatitis B core antibody (anti‐HBc) following IVIG administration is a well‐recognized, but often underappreciated phenomenon that can complicate the interpretation of hepatitis B serologies.
Mark McPherson, Alexandra Jianu, Winn Chatham   +2 more
wiley   +1 more source

Large‐Scale Autoantibody Reactome Analysis Reveals Shared and Specific Signatures Across Different Immune‐Mediated Inflammatory Diseases

ACR Open Rheumatology, Volume 8, Issue 8, August 2026.
Objective The shared and disease‐specific mechanisms across the immune‐mediated inflammatory diseases (IMIDs) spectrum remains incompletely characterized, despite the recognized role of autoantibodies as important indicators of immune tolerance breakdown and immune dysregulation. Methods Autoantibody reactome profiling of IgG and IgA autoantibodies was
Zhou Bai, Bomiao Yu, Zimo Wei, Pancheng Xiao, Minghua Zhan, Mansheng Li, Fang Wang, Yongjing Cheng, Minshu Zhao, Chao Zhang, Xuan Zhang, Xiaobo Yu, Yudong Liu   +12 more
wiley   +1 more source